Using circulating tumour DNA dynamics to predict outcomes in advanced cancers
Using circulating tumour DNA dynamics to predict outcomes in advanced cancers
OncoAlert and ecancer weekly roundup for November 8 - 14, 2020
OncoAlert and ecancer weekly roundup for November 2 - 7, 2020
Evolving concepts in the diagnosis and staging of multiple myeloma
SAFIR 02: Durvalumab compared to maintenance chemotherapy for metastatic non-small cell lung cancer
Managing multiple myeloma during the COVID-19 pandemic in Brazil
Critical issues in drug and biomarker development
OncoAlert and ecancer weekly roundup for October 26 - 31, 2020
Pragmatic geriatric assessment for cancer patients in Brazil
Biomarker-driven clinical trials: promises and pitfalls
Key themes, highlights and importance of this year's IBCD 2020 meeting
How current assay approval policies are leading to unintended imprecision medicine